Skip to main content
Clinical Trials/EUCTR2004-001474-12-GB
EUCTR2004-001474-12-GB
Active, not recruiting
Phase 1

A Proof Of Concept Study to Investigate the Clinical, Histological And Molecular Predictors of Response to Oral and Intranasal Corticosteroid in Nasal Polyposis - Prednisolone Induction

Research and Innovation Services0 sites120 target enrollmentFebruary 14, 2005

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
asal Polyposis
Sponsor
Research and Innovation Services
Enrollment
120
Status
Active, not recruiting
Last Updated
9 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
February 14, 2005
End Date
TBD
Last Updated
9 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Sponsor
Research and Innovation Services

Eligibility Criteria

Inclusion Criteria

  • Male or Female Participants 16\-75, with bilateral nasal polyposis of grade 2\-3\.
  • Are the trial subjects under 18? yes
  • Number of subjects for this age range:
  • F.1\.2 Adults (18\-64 years) yes
  • F.1\.2\.1 Number of subjects for this age range
  • F.1\.3 Elderly (\>\=65 years) yes
  • F.1\.3\.1 Number of subjects for this age range

Exclusion Criteria

  • Patients who have used oral or nasule steroids within the preceding 3 months.
  • Pregnant or breastfeeding mothers, or those taking inadequate contraceptive measures.

Outcomes

Primary Outcomes

Not specified

Similar Trials